CADL · Company research
Candel Therapeutics, Inc. (CADL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 9.82 | $697,829,627.43 | 502995627.43 | 198.8000000000000000 | — | — | — | 5.0556740064044512 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.